우수사례 | Best Practice and Cases in Lottery and Gambling | 最佳实践
- date : 2015-05-20 01:10|hit : 1946
-
- Article] Mucosal carcinoma of the fallopian tube coexists with ovarian cancer of serous subtype only: a study of Japanese cases
-
DocNo of ILP: 2454
Doc. Type: Article
Title: Mucosal carcinoma of the fallopian tube coexists with ovarian cancer of serous subtype only: a study of Japanese cases
Authors: Maeda, D; Ota, S; Takazawa, Y; Ohashi, K; Mori, M; Imamura, T; Nakagawa, S; Yano, T; Taketani, Y; Fukayama, M
Full Name of Authors: Maeda, Daichi; Ota, Satoshi; Takazawa, Yutaka; Ohashi, Kenichi; Mori, Masaya; Imamura, Tetsuo; Nakagawa, Shunsuke; Yano, Tetsu; Taketani, Yuji; Fukayama, Masashi
Keywords by Author: Ovarian carcinoma; Fallopian tube; Mucosal carcinoma; p53
Keywords Plus: CLEAR-CELL CARCINOMA; INTRAEPITHELIAL CARCINOMA; MUTATION CARRIERS; POOR-PROGNOSIS; CARCINOGENESIS; ENDOMETRIOSIS; OOPHORECTOMY; PATHOGENESIS; ASSOCIATION; PRECURSOR
Abstract: Previous studies in Western countries have revealed that mucosal carcinoma of the fallopian tube frequently coexists with pelvic (ovarian, tubal, and peritoneal) serous carcinomas, and early tubal carcinoma is now regarded as a possible origin of these tumors. However, the relationship between early tubal carcinoma and non-serous ovarian cancer, such as clear cell adenocarcinoma, has not been studied in detail. In this study, we sought to examine the coexistence of mucosal carcinoma of the fallopian tube in Japanese ovarian cancer cases. We submitted the fallopian tubes in toto for histological examination in 52 ovarian carcinoma cases and three peritoneal serous carcinoma cases. The ovarian tumors included 12 serous adenocarcinomas, 23 clear cell adenocarcinomas, nine endometrioid adenocarcinomas, three mucinous adenocarcinomas, and four mixed epithelial carcinomas. Mucosal carcinoma of the fallopian tube did not coexist with non-serous adenocarcinoma (n=40). In contrast, mucosal carcinoma of the fallopian tube was observed in six cases of ovarian serous adenocarcinoma and one case of peritoneal serous adenocarcinoma. In these cases, the p53 immunophenotypes were similar in tubal lesions and invasive ovarian or peritoneal carcinomas. Tumors were negative for p53 in four of seven cases, and one of the p53-negative serous adenocarcinomas showed low-grade morphology. We believe that some ovarian and peritoneal serous adenocarcinomas develop from early tubal carcinomas. However, it should be noted that early tubal carcinomas are not always p53-positive immunohistochemically. Finally, it is unlikely that early tubal lesions are involved in the carcinogenesis of clear cell adenocarcinoma and other non-serous adenocarcinomas.
Cate of OECD: Basic medicine
Year of Publication: 2010
Business Area: other
Detail Business: medicine & science
Country: USA
Study Area:
Name of Journal: VIRCHOWS ARCHIV
Language: English
Country of Authors: [Maeda, Daichi; Ota, Satoshi; Takazawa, Yutaka; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo 1130033, Japan; [Ohashi, Kenichi] Toranomon Gen Hosp, Dept Pathol, Tokyo, Japan; [Mori, Masaya] Mitsui Mem Hosp, Dept Pathol, Tokyo 101, Japan; [Imamura, Tetsuo] Teikyo Univ Hosp, Dept Pathol, Tokyo, Japan; [Nakagawa, Shunsuke; Yano, Tetsu; Taketani, Yuji] Univ Tokyo, Dept Obstet & Gynecol, Grad Sch Med, Tokyo, Japan
Press Adress: Fukayama, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Pathol, 7-3-1 Hongo Bunkyoku, Tokyo 1130033, Japan.
Email Address: mfukayama-tky@umin.net
Citaion:
Funding:
Lists of Citation: Anttila MA, 1999, INT J GYNECOL PATHOL, V18, P42, DOI 10.1097/00004347-199901000-00006; Benedet JL, 2000, INT J GYNECOL OBSTET, V70, P209; Boyd J, 2003, GYNECOL ONCOL, V88, pS8, DOI 10.1006/gyno.2002.6674; Colgan TJ, 2001, AM J SURG PATHOL, V25, P1283, DOI 10.1097/00000478-200110000-00009; Crum CP, 2007, CURR OPIN OBSTET GYN, V19, P3, DOI 10.1097/GCO.0b013e328011a21f; Finch A, 2006, GYNECOL ONCOL, V100, P58, DOI 10.1016/j.ygyno.2005.06.065; Fukunaga M, 1997, HISTOPATHOLOGY, V30, P249, DOI 10.1046/j.1365-2559.1997.d01-592.x; Holstege H, 2009, CANCER RES, V69, P3625, DOI 10.1158/0008-5472.CAN-08-3426; Itamochi H, 2008, CANCER SCI, V99, P653, DOI 10.1111/j.1349-7006.2008.00747.x; Jarboe E, 2008, INT J GYNECOL PATHOL, V27, P1, DOI 10.1097/pgp.0b013e31814b191f; KATABUCHI H, 2008, NIPPON SANKA FUJINHA, V60, P224; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; Kobel M, 2009, AM J SURG PATHOL, V33, P14, DOI 10.1097/PAS.0b013e3181788546; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Lee Y, 2006, ADV ANAT PATHOL, V13, P1, DOI 10.1097/01.pap.0000201826.46978.e5; Levanon K, 2008, J CLIN ONCOL, V26, P5284, DOI 10.1200/JCO.2008.18.1107; Maeda D, 2010, INT J GYNECOL PATHOL, V29, P273, DOI 10.1097/PGP.0b013e3181c30301; Malpica A, 2008, INT J GYNECOL PATHOL, V27, P175, DOI 10.1097/PGP.0b013e31816085e0; Malpica A, 2004, AM J SURG PATHOL, V28, P496, DOI 10.1097/00000478-200404000-00009; Medeiros F, 2006, AM J SURG PATHOL, V30, P230, DOI 10.1097/01.pas.0000180854.28831.77; Modesitt SC, 2002, OBSTET GYNECOL, V100, P788, DOI 10.1016/S0029-7844(02)02149-X; Okuda T, 2003, GYNECOL ONCOL, V88, P318, DOI 10.1016/S0090-8258(02)00149-X; Powell CB, 2005, J CLIN ONCOL, V23, P127, DOI 10.1200/JCO.2005.04.109; Roh MH, 2009, AM J SURG PATHOL, V33, P376, DOI 10.1097/PAS.0b013e3181868904; Salvador S, 2008, GYNECOL ONCOL, V110, P408, DOI 10.1016/j.ygyno.2008.05.010; Schorge JO, 1998, J NATL CANCER I, V90, P841, DOI 10.1093/jnci/90.11.841; SEIDMAN JD, 2002, BLAUSTEINS PATHOLOGY, P873; Shaw PA, 2002, INT J GYNECOL PATHOL, V21, P407, DOI 10.1097/PGP.0000035810.01856.c8; Shaw PA, 2009, MODERN PATHOL, V22, P1133, DOI 10.1038/modpathol.2009.89; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; Tavassoli FA, 2003, PATHOLOGY GENETICS T
Number of Citaion: 32
Publication: SPRINGER
City of Publication: NEW YORK
Address of Publication: 233 SPRING ST, NEW YORK, NY 10013 USA
ISSN: 0945-6317
29-Character Source Abbreviation: VIRCHOWS ARCH
ISO Source Abbreviation: Virchows Arch.
Volume: 457
Version: 5
Start of File: 597
End of File: 608
DOI: 10.1007/s00428-010-0979-4
Number of Pages: 12
Web of Science Category: Pathology
Subject Category: Pathology
Document Delivery Number: 682CD
Unique Article Identifier: WOS:000284376400010
[이 게시물은 HyeJung Mo…님에 의해 2015-05-20 20:25:56 GAMBLING에서 이동 됨]
- reply : 0
-
- list
-
- prev